While the former Biden administration showcased the Inflation Reduction Act as a key victory in the fight over high drug ...

The 119th Congress and the Trump Administration have before them significant challenges for long-term healthcare reforms. | To help prevent painful injuries and costly hospitalizations, and reduce ...

House Democrats want to know what the Trump administration plans to do after it rescinded a Biden-era executive order to ...

Robert F. Kennedy Jr., nominee for HHS secretary, seemed unfamiliar with the massive insurance program during Thursday’s ...

The HHS Secretary nominee confused Medicare and Medicaid programs, though he would be responsible for them if confirmed. We ...

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

Healthcare Management Solutions LLC can perform a $41 million auditing services task order for the Centers of Medicare and Medicaid Services despite the agency’s improper discussions, the US Court of ...

According to Grand View Research, the European and Middle Eastern drug screening markets are projected to grow significantly by 2030, with Europe expected to reach $3.6 billion and the Middle East and ...

The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.

LeadingAge urged the Centers for Medicare and Medicaid Services to step up its oversight of MA insurers’ use of AI.

Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...

Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.